Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Valeo Pharma Inc
T.VPH
Alternate Symbol(s):
VPHIF
|
T.VPH.DB
Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,...
Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:VPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(2708)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Mar 24, 2022 6:21pm
Q1-2022 Webcast and Conference Call
Valeo will host a conference call to discuss its first quarter 2022 results and highlights on Friday March 25, 2022 at 8.30am (ET). The telephone numbers to access the conference call
...more
(2708)
•••
Betteryear2
X
View Profile
View Bullboard History
Comment by
Betteryear2
on Mar 24, 2022 6:16pm
RE:FIRST QUARTER 2022 RESULTS AND HIGHLIGHTS
https://www.newswire.ca/en/releases/archive/March2022/24/c0547.html
(2708)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Mar 24, 2022 6:14pm
FIRST QUARTER 2022 RESULTS AND HIGHLIGHTS
Q1-22 revenues of $4.2 million, up 128% over Q1-21 Q1-22 gross margins of $1.4 million, up 266% over Q1-21 Public reimbursement secured in key provinces for
...more
(19)
•••
CanadianJrs
X
View Profile
View Bullboard History
Post by
CanadianJrs
on Mar 11, 2022 8:58am
Yesterrday interview
(19)
•••
CanadianJrs
X
View Profile
View Bullboard History
Post by
CanadianJrs
on Mar 09, 2022 6:12pm
What happened?
Can anyone figure out why there was a 15% drop today on exceptional daily volume? I've been looking and so far only found a poorly done article by Simply Wall Street from this morning.
(37)
•••
bmreed
X
View Profile
View Bullboard History
Post by
bmreed
on Mar 06, 2022 12:30pm
Webinar Recap w Radius Research and $VPH CEO Steve Saviuk
Webinar Recap: Valeo Pharma (VPH) w CEO Steve Saviuk - Commercializing Innovative Prescription Products in Canada - Pitch, Deep Dive and Q&A - https://www.youtube.com/watch?v=8hQ51RBuPUA {
...more
(9)
•••
Royal10
X
View Profile
View Bullboard History
Post by
Royal10
on Mar 01, 2022 10:23am
VPH: Strong year-end results today!
This morning, Valeo Pharma published RECORD ANNUAL REVENUES FOR FISCAL 2021! Trading at 66 cents, VPH is way undervalued and is a potential double with strong prospect for 2022
...more
(19)
•••
CanadianJrs
X
View Profile
View Bullboard History
Post by
CanadianJrs
on Mar 01, 2022 7:27am
financial results
https://www.newswire.ca/news-releases/valeo-pharma-reports-record-annual-revenues-for-fiscal-2021-836971982.html
(19)
•••
CanadianJrs
X
View Profile
View Bullboard History
Post by
CanadianJrs
on Feb 28, 2022 6:55pm
Financials
The year end financials are out on Sedar.
(37)
•••
bmreed
X
View Profile
View Bullboard History
Post by
bmreed
on Feb 24, 2022 6:55pm
Webinar w VPH CEO Steve Saviuk - Tue, Mar 1 @ 12:30PM ET
Webinar - Valeo Pharma (VPH) w/ CEO Steve Saviuk Tue, Mar 1 at 12:30pm ET / 9:30am PT Q&A with Radius Research Register Here - https://us02web.zoom.us/webinar/register
...more
(2708)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Feb 24, 2022 8:43am
VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT
Atectura and Enerzair also now reimbursed by the Non-Insured Health Benefits ("NIHB") program of Indigenous Services Canada and Veteran Affairs Canada ("VAC")
...more
(19)
•••
CanadianJrs
X
View Profile
View Bullboard History
Comment by
CanadianJrs
on Feb 18, 2022 11:22am
RE:RE:When
Yeah something weird is going on. I hope Fidelity drives the price up. I have 22,000 warrants currently that I'd like to use to buy shares rather than exercise them at $1.50 with a share price so
...more
(0)
•••
SweetRelish
X
View Profile
View Bullboard History
Comment by
SweetRelish
on Feb 17, 2022 3:23pm
RE:When
I also bought some shares and the same happened. There seems to be an arrangement within a few brokage firms to keep it low. Fidelity has several warrents. They will drive it up starting early
...more
(19)
•••
CanadianJrs
X
View Profile
View Bullboard History
Post by
CanadianJrs
on Feb 17, 2022 11:23am
When
When will management have things in place to get on the TSX. This is sickening. I bought more shares today. Not much but still increasing my holdings so still trying to buy 1000 shares at least once a
...more
(13075)
•••
SusanBolland
X
View Profile
View Bullboard History
Comment by
SusanBolland
on Feb 04, 2022 6:10am
RE:VPH: VALEO PHARMA offers COVID-19 product for immune support
sweet
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >